Ambiq Micro CEO Fumihide Esaka sells 109,821 shares
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Ambiq Micro, Inc. (AMBQ) Chief Executive Officer Fumihide Esaka exercised options for 109,821 common shares on November 12, 13 and 16, 2026, at exercise prices of $12.60 and $8.12 per share, and reported sales of 109,821 shares on those dates. Reported sale prices ranged from $43.9163 to $51.45 per share; footnotes identify several prices as weighted averages for multiple transactions. The transactions were under a Rule 10b5-1 plan; the footnote tied to the November 16 transactions gives May 15, 2026 as the plan’s adoption date.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) F8, F12 | 5,000 | $0.00 | $0.00 |
| Exercise | Common Stock F8 | 5,000 | $8.12 | $41K |
| Sale | Common Stock F8, F9 | 3,300 | $43.9163 | $145K |
| Sale | Common Stock F8, F10 | 1,700 | $44.4322 | $76K |
| Exercise | Stock Option (Right to Buy) F11 | 54,821 | $0.00 | $0.00 |
| Exercise | Common Stock | 54,821 | $12.60 | $691K |
| Sale | Common Stock F4 | 5,600 | $45.4478 | $255K |
| Sale | Common Stock F5 | 9,325 | $46.1061 | $430K |
| Sale | Common Stock F6 | 38,496 | $47.2925 | $1.82M |
| Sale | Common Stock F7 | 1,400 | $48.4423 | $68K |
| Exercise | Stock Option (Right to Buy) F11 | 50,000 | $0.00 | $0.00 |
| Exercise | Common Stock | 50,000 | $12.60 | $630K |
| Sale | Common Stock F1 | 17,400 | $48.7624 | $848K |
| Sale | Common Stock F2 | 16,200 | $49.9301 | $809K |
| Sale | Common Stock F3 | 16,000 | $50.7148 | $811K |
| Sale | Common Stock | 400 | $51.45 | $21K |
Footnotes (12)
- F1. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $48.40 to $49.37 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F2. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $49.41 to $50.40 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F3. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $50.42 to $51.38 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F4. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.68 to $45.65 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F5. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $45.69 to $46.68 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F6. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.69 to $47.67 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F7. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $47.71 to $48.55 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F8. The transactions occurred under a Rule 10b5-1 plan adopted by the Reporting Person on May 15, 2026.
- F9. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $43.20 to $44.19 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F10. The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $44.21 to $45.03 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- F11. 1/4 of the shares subject to the option vested on January 1, 2024, and 1/48 of the shares subject to the option vest in equal monthly installments thereafter, subject to the Reporting Person's continued service.
- F12. 1/4 of the shares subject to the option vested on February 21, 2020, and 1/48 of the shares subject to the option vested in equal monthly installments thereafter, subject to the Reporting Person's continued service.
Key Figures
Key Terms
Rule 10b5-1 plan financial
weighted average sale price financial
vested in equal monthly installments technical
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What options did Ambiq Micro CEO Fumihide Esaka exercise?
AI-generated analysis. How Rhea-AI works. Not financial advice.